The research evidence supporting BPC-157 spans over 100 peer-reviewed publications
It has been used to treat conditions such as inflammatory bowel disease (IBD), ulcers, and leaky gut syndrome by promoting mucosal healing and reducing inflammation within the gut (Jain et al., 2021)
Lipo-Mino is commonly used alongside GLP-1 medications
Additionally, a combination therapy involving glucose, niacin, and N-acetylcysteine has been shown to synergistically improve respiratory chain complex I dysfunction, reduce mitochondrial stress, and boost metabolic and glutathione levels, thereby increasing resilience and preventing acute neurological and biochemical decompensation
Contact us today to discuss inventory availability, volume requirements, and long-term supply opportunities.